newsfilter
← Latest News
Business Wire·

cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina

cbdMD, Inc. (NYSE:YCBD, YCBDpA))) (the "Company"), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has commenced a preclinical human study with researchers at the University of South Carolina.